Le pharmacien d’officine, acteur de la prise en charge du patient atteint de dégénérescence maculaire liée à l’âge (DMLA)

Read full text Summarise with VIRAT
Authors: Hugo Amar
Cited by: 0
References: 28

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Age-related macular degeneration (AMD) is the leading cause of visual impairment in France. It involves damage to the macula, thereby affecting central vision and compromising patients’ autonomy (reading, driving, etc.). The disease is promoted by factors such as age, smoking, and few genetic susceptibilities. Two advanced phenotypes are distinguished: neovascular (wet) AMD, defined by the development of choroidal neovascularisation leading to an abrupt loss of visual acuity and treated with intravitreal injections; and atrophic (dry) AMD, for which there is no reference therapy, characterised by a slow course with the appearance of geographic atrophy. The aim of this thesis is to examine the role of the community pharmacist in identifying and supporting patients, informed by an analysis of real-world practice in pharmacies and patient feedback. It also explores the paradox of dietary supplements, which are increasingly promoted in pharmacies. Evidence from major trials (AREDS 1 and 2) indicates that these formulations are neither curative nor preventive, but reduce progression to advanced AMD when used appropriately. The survey of community health professionals reveals heterogeneity in knowledge, varying by profession and age. These findings support the development of standardised tools (common messages, reference guides, shared protocols) to ensure continuity between ophthalmologists and pharmacists. Community pharmacists thus emerge as central actors in the management of AMD, with key future directions including enhanced training, strengthened collaboration with ophthalmologists, and formal evaluation of the impact of pharmacy-based interventions and counselling.

Fields of Study & Subjects

Pharmacy and Medical Practices Retinal Diseases and Treatments Complementary and Alternative Medicine Studies

Publication details

Journal / source
HAL
Publication date
9 March 2026
Language
FR
Document type
Thesis